Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 7, 2004

View Archived Issues

Celltech Details Phase III Trial Plans For CDP870 In Crohn's

A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International) Read More

Innogenetics Forms Hepatitis C Union With Roche Diagnostics

Researchers Find Gene Similar To BRCA1 In Nematode Worm

SkyePharma Disputing GSK's Royalty Payment For Paxil CR

Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

Eirx Seeks To Raise £1M Via Initial Public Offering On AIM

U.S. Navy To Evaluate Inovio's DNA Vaccine Delivery System

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.